CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Shionogi & Co., Ltd. - 4507 CFD

Market is not available at the moment

Market information is presented
as of 2023-09-21

  • Summary
Trading Conditions
Spread 44.0
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.010986 %
Charges from full value of position ($-2.09)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.010986%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.011237 %
Charges from full value of position ($-2.14)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.011237%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency JPY
Margin 5%
Stock exchange Japan
Commission on trade 0%

*Information provided by Capital.com

Shionogi & Co Ltd ESG Risk Ratings

High Medium Low Negligible

‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

More ESG coverage

Key Stats
Prev. Close* 6822.1
Open* 6783.2
1-Year Change* 17.2%
Day's Range* 6783.2 - 6874.9
52 wk Range 5,718.00-7,593.00
Average Volume (10 days) 1.05M
Average Volume (3 months) 25.78M
Market Cap 1,973.11B
P/E Ratio 9.84
Shares Outstanding 294.31M
Revenue 464.16B
EPS 652.02
Dividend (Yield %) 2.10313
Beta 0.91
Next Earnings Date Oct 30, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

Date Close Change Change (%) Open High Low
Jun 30, 2022 6828.0 44.8 0.66% 6783.2 6874.9 6783.2
Jun 29, 2022 6822.1 -19.9 -0.29% 6842.0 6870.9 6811.1
Jun 28, 2022 6837.0 109.7 1.63% 6727.3 6843.0 6699.4
Jun 27, 2022 6732.3 90.8 1.37% 6641.5 6755.2 6641.5
Jun 24, 2022 6698.4 308.3 4.82% 6390.1 6701.4 6390.0
Jun 23, 2022 6389.2 222.4 3.61% 6166.8 6483.9 6089.9
Jun 22, 2022 6771.2 -1.0 -0.01% 6772.2 6847.0 6739.3
Jun 21, 2022 6688.4 84.8 1.28% 6603.6 6719.3 6557.7
Jun 20, 2022 6559.7 6.0 0.09% 6553.7 6589.7 6470.0
Jun 17, 2022 6503.9 48.9 0.76% 6455.0 6556.8 6453.0
Jun 16, 2022 6633.6 -20.9 -0.31% 6654.5 6754.2 6586.7
Jun 15, 2022 6485.9 -163.6 -2.46% 6649.5 6649.5 6459.0
Jun 14, 2022 6716.3 -4.0 -0.06% 6720.3 6740.3 6661.5
Jun 13, 2022 6802.1 -61.8 -0.90% 6863.9 6890.9 6763.2
Jun 10, 2022 6990.6 -24.9 -0.35% 7015.5 7037.5 6983.6
Jun 9, 2022 7125.3 -51.8 -0.72% 7177.1 7244.0 7104.3
Jun 8, 2022 7100.3 153.6 2.21% 6946.7 7100.3 6940.8
Jun 7, 2022 6904.8 70.8 1.04% 6834.0 6916.8 6834.0
Jun 6, 2022 6842.0 52.9 0.78% 6789.1 6850.0 6783.2
Jun 3, 2022 6761.2 67.8 1.01% 6693.4 6790.1 6693.4

Shionogi & Co., Ltd. Events

Time (UTC) Country Event
Thursday, September 28, 2023

Time (UTC)

12:00

Country

JP

Event

Shionogi & Co Ltd
Shionogi & Co Ltd

Forecast

-

Previous

-
Monday, October 30, 2023

Time (UTC)

04:00

Country

JP

Event

Q2 2024 Shionogi & Co Ltd Earnings Release
Q2 2024 Shionogi & Co Ltd Earnings Release

Forecast

-

Previous

-
Monday, January 29, 2024

Time (UTC)

04:00

Country

JP

Event

Q3 2024 Shionogi & Co Ltd Earnings Release
Q3 2024 Shionogi & Co Ltd Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total revenue 426684 335138 297177 333371 367960
Revenue 426684 335138 297177 333371 367960
Cost of Revenue, Total 62246 55415 52523 56782 55591
Gross Profit 364438 279723 244654 276589 312369
Total Operating Expense 277681 224826 179739 202879 223635
Selling/General/Admin. Expenses, Total 93637 87877 88387 91802 85285
Research & Development 102392 72996 54249 47949 52058
Unusual Expense (Income) 10210 334 1286 -1781 19272
Other Operating Expenses, Total 1305 814 -23430 1580 4773
Operating Income 149003 110312 117438 130492 144325
Interest Income (Expense), Net Non-Operating 70502 16224 26157 29503 30936
Other, Net 827 -268 -577 -1479 -1218
Net Income Before Taxes 220332 126268 143018 158516 174043
Net Income After Taxes 184496 113439 112062 122194 136919
Minority Interest 469 746 -203 1 272
Net Income Before Extra. Items 184965 114185 111859 122195 137191
Net Income 184965 114185 111859 122195 137191
Total Adjustments to Net Income -1 -2 0
Income Available to Common Excl. Extra. Items 184965 114185 111858 122193 137191
Income Available to Common Incl. Extra. Items 184965 114185 111858 122193 137191
Dilution Adjustment
Diluted Net Income 184965 114185 111858 122193 137191
Diluted Weighted Average Shares 297.805 301.579 306.554 309.13 315.576
Diluted EPS Excluding Extraordinary Items 621.094 378.624 364.888 395.28 434.732
Dividends per Share - Common Stock Primary Issue 135 115 108 103 94
Diluted Normalized EPS 649.802 379.619 368.175 390.839 482.775
Depreciation / Amortization 7858 7370 6724 6547 6656
Interest Expense (Income) - Net Operating 33 20
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 109311 88337 187568 78939 71839
Revenue 109311 88337 187568 78939 71839
Cost of Revenue, Total 13119 17680 17199 14421 12945
Gross Profit 96192 70657 170369 64518 58894
Total Operating Expense 62726 85807 69319 63137 59418
Selling/General/Admin. Expenses, Total 23191 27089 24168 24069 22447
Research & Development 24997 27584 26078 26198 22530
Depreciation / Amortization 849 846 923 995 956
Other Operating Expenses, Total 570 12608 951 -2546 540
Operating Income 46585 2530 118249 15802 12421
Interest Income (Expense), Net Non-Operating 9119 19016 12559 11865 27889
Other, Net
Net Income Before Taxes 55704 21546 130808 27667 40310
Net Income After Taxes 42214 26723 100366 22981 34426
Minority Interest 347 512 99 -438 295
Net Income Before Extra. Items 42561 27235 100465 22543 34721
Net Income 42561 27235 100465 22543 34721
Income Available to Common Excl. Extra. Items 42562 27236 100464 22542 34722
Income Available to Common Incl. Extra. Items 42562 27236 100464 22542 34722
Diluted Net Income 42562 27236 100464 22542 34722
Diluted Weighted Average Shares 294.406 294.406 295.501 300.73 301.583
Diluted EPS Excluding Extraordinary Items 144.569 92.5117 339.979 74.9576 115.132
Dividends per Share - Common Stock Primary Issue 0 75 0 60 0
Diluted Normalized EPS 144.569 92.5117 339.979 74.9576 115.132
Total Adjustments to Net Income 1 1 -1 -1 1
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total Current Assets 784192 659205 556238 516026 493645
Cash and Short Term Investments 563355 465177 418324 380018 346330
Cash & Equivalents 309224 184420 196173 208861 195800
Short Term Investments 254131 280757 222151 171157 150530
Total Receivables, Net 109842 123016 78211 79996 101346
Accounts Receivable - Trade, Net 109309 122544 77178 79345 100449
Total Inventory 57919 45892 38003 33818 35125
Other Current Assets, Total 53076 25120 21700 22194 10844
Total Assets 1311800 1150600 998992 873695 938540
Property/Plant/Equipment, Total - Net 118567 112417 95710 76007 76901
Property/Plant/Equipment, Total - Gross 295126 284453 262101 255228 252502
Accumulated Depreciation, Total -176559 -172037 -166391 -179222 -175601
Goodwill, Net 9819 9638 9357 7854 3358
Intangibles, Net 96309 81223 76558 51705 47804
Long Term Investments 274093 269151 244196 204657 302709
Other Long Term Assets, Total 28820 18967 16933 17446 14123
Total Current Liabilities 158552 124396 100180 81119 96149
Accounts Payable 14005 16372 9902 10763 9442
Accrued Expenses
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 141533 105079 86899 66995 82483
Total Liabilities 211754 174940 152884 108543 129766
Total Long Term Debt 6397 3729 4608 4791 6006
Long Term Debt 0
Deferred Income Tax 5916 7807 7749 1949 444
Minority Interest 21832 17624 18442 51 4313
Other Liabilities, Total 19057 21384 21905 20633 22854
Total Equity 1100050 975661 846108 765152 808774
Common Stock 21279 21279 21279 21279 21279
Additional Paid-In Capital 15204 14455 13733 21025 21277
Retained Earnings (Accumulated Deficit) 940606 832958 752248 708291 613483
Treasury Stock - Common -63074 -57857 -57989 -77292 -28882
Unrealized Gain (Loss) 1 1
Other Equity, Total 186030 164826 116837 91849 181616
Total Liabilities & Shareholders’ Equity 1311800 1150600 998992 873695 938540
Total Common Shares Outstanding 294.306 301.483 301.464 303.784 311.287
Current Port. of LT Debt/Capital Leases 3014 2945 3379 3361 4224
Capital Lease Obligations 6397 3729 4608 4791 6006
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total Current Assets 784192 749552 679927 683921 659205
Cash and Short Term Investments 563355 492065 488563 502804 465177
Cash & Equivalents 309224 218669 198043 204629 254420
Short Term Investments 254131 273396 290520 298175 210757
Total Receivables, Net 109842 164358 99719 98538 123016
Accounts Receivable - Trade, Net 109309 164334 99661 97928 122544
Total Inventory 57919 58688 56069 52061 45892
Other Current Assets, Total 53076 34441 35576 30518 25120
Total Assets 1311800 1261620 1195940 1200960 1150600
Property/Plant/Equipment, Total - Net 118567 115980 113527 114772 112417
Goodwill, Net 9819 10075 10077 9864 9638
Intangibles, Net 96309 108208 108494 97125 81223
Long Term Investments 274093 261888 266357 277129 269151
Other Long Term Assets, Total 28820 15913 17557 18146 18967
Total Current Liabilities 158552 145322 127003 129836 124396
Accounts Payable 14005 16780 17844 15579 16372
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 3014 2778 2967 2971 2945
Other Current Liabilities, Total 141533 125764 106192 111286 105079
Total Liabilities 211754 206376 186360 186595 174940
Total Long Term Debt 6397 5879 3848 3675 3729
Capital Lease Obligations 6397 5879 3848 3675 3729
Deferred Income Tax 5916 8254 8877 8456 7807
Minority Interest 21832 23286 23414 22154 17624
Other Liabilities, Total 19057 23635 23218 22474 21384
Total Equity 1100050 1055240 1009580 1014360 975661
Common Stock 21279 21279 21279 21279 21279
Additional Paid-In Capital 15204 15204 15204 15204 14455
Retained Earnings (Accumulated Deficit) 940606 937461 853614 849226 832958
Treasury Stock - Common -63074 -89349 -63263 -57858 -57857
Unrealized Gain (Loss) 1 170645 182744 186510
Other Equity, Total 186030 1 1 164826
Total Liabilities & Shareholders’ Equity 1311800 1261620 1195940 1200960 1150600
Total Common Shares Outstanding 294.306 294.307 301.117 301.483 301.483
Property/Plant/Equipment, Total - Gross 295126 284453
Accumulated Depreciation, Total -176559 -172037
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Net income/Starting Line 220332 126268 143018 158516 174043
Cash From Operating Activities 177866 102068 109039 131940 165000
Cash From Operating Activities 17165 16351 14779 14115 14431
Amortization
Non-Cash Items -59703 -15456 -25011 -29133 17168
Cash Taxes Paid 27284 26038 32254 48354 23499
Cash Interest Paid 94 87 256 348 33656
Changes in Working Capital 72 -25095 -23747 -11558 -40642
Cash From Investing Activities -48292 -96204 -5261 -29144 -56256
Capital Expenditures -37187 -31564 -32944 -11768 -25395
Other Investing Cash Flow Items, Total -11105 -64640 27683 -17376 -30861
Cash From Financing Activities -84123 -36615 -43891 -88174 -89912
Financing Cash Flow Items 4716 -2 8886 -3349 1019
Total Cash Dividends Paid -36142 -33146 -32529 -31122 -27639
Issuance (Retirement) of Stock, Net -49539 -14 -16600 -50159 -50270
Foreign Exchange Effects 9352 8998 7425 -1560 832
Net Change in Cash 54803 -21753 67312 13062 19664
Issuance (Retirement) of Debt, Net -3158 -3453 -3648 -3544 -13022
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 220332 198786 67978 40310 126268
Cash From Operating Activities 177866 116387 58370 38249 102068
Cash From Operating Activities 17165 12950 8645 4300 16351
Non-Cash Items -59703 -53546 -39949 -27091 -15456
Cash Taxes Paid 27284 28042 12150 12132 26038
Cash Interest Paid 94 56 44 26 87
Changes in Working Capital 72 -41803 21696 20730 -25095
Cash From Investing Activities -48292 -79298 -90374 -82474 -96204
Capital Expenditures -37187 -34488 -31284 -18330 -31564
Other Investing Cash Flow Items, Total -11105 -44810 -59090 -64144 -64640
Cash From Financing Activities -84123 -83633 -38448 -14221 -36615
Financing Cash Flow Items 4716 4716 4716 4712 -2
Total Cash Dividends Paid -36142 -36164 -18078 -18089 -33146
Issuance (Retirement) of Stock, Net -49539 -49535 -23355 -1 -14
Issuance (Retirement) of Debt, Net -3158 -2650 -1731 -843 -3453
Foreign Exchange Effects 9352 10793 14074 8654 8998
Net Change in Cash 54803 -35751 -56378 -49792 -21753

Shionogi & Co., Ltd. Company profile

About Shionogi & Co Ltd

Shionogi & Co., Ltd. is a Japan-based pharmaceutical company mainly engaged in the research, development, purchase, manufacture and sale of pharmaceuticals, as well as pharmaceutical-related businesses. The prescription drug business is engaged in the development of eight new drugs including hypercholesterolemia treatment drugs Crestor, antihypertensive drugs Ilbetan Family (Irbetan, Aimix, Iltra) and antidepressant drugs Sinbalta. The Company is engaged in the provision of information to contribute to medical care by maximizing its products. The over-the-counter (OTC) pharmaceutical business handles products tailored to customers' lifestyles. The in-vitro diagnostics business is engaged in the sale of products, as well as the provision of information on infectious diseases, cardiovascular diseases and allergic diseases. The Company mainly provides its products and services in Japan, Europe and North America markets.

Financial summary

BRIEF: For the nine months ended 31 December 2021, Shionogi & Co Ltd revenues decreased 2% to Y219.62B. Net income applicable to common stockholders decreased 20% to Y71B. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income also reflects Other income decrease of 93% to Y1.74B (income), Research&Development Expenses-SGA increase of 23% to Y48.22B (expense).

Equity composition

FY'99-FY'02 WAS and FY'04 DPS were estimated. FY'05-'07 1&3Q WAS was estimated and used as O/S. FY'08 3Q WAS was estimated and used for O/S. FY'08 1Q & 3Q WAS=O/S.

Industry: Pharmaceuticals (NEC)

道修町3丁目1番8号
中央区
OSAKA-SHI
OSAKA-FU 541-0045
JP

News

EUR/USD tests key support

EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

14:32, 21 September 2023
Bank of England building

BoE leaves rates unchanged, GBP drops further as investors look for more clarity

The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

11:45, 21 September 2023
British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

GBP softer after CPI surprise, JPY focused on any further hints from Ueda

GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

12:42, 20 September 2023

How to Trade The Break & Retest

In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

11:59, 20 September 2023

Cable coils near lows ahead of Fed and BoE rate decisions

It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.

14:16, 19 September 2023

FTSE 100 Technical Outlook - 18 September 2023

In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.

06:55, 19 September 2023
View of the City of London’s illuminated financial district skyline at dusk

Market Analysis: FTSE 100 boosted by ECB rate hike end and iron ore rally

The FTSE 100 rose over 2% on Thursday as the ECB announced no more rate hikes for now.

13:46, 15 September 2023

People also watch

US100

14,682.60 Price
-1.830% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 21:00 (UTC)
Spread 7.0

XRP/USD

0.51 Price
-2.100% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01192

Oil - Crude

89.44 Price
+0.350% 1D Chg, %
Long position overnight fee 0.0355%
Short position overnight fee -0.0574%
Overnight fee time 21:00 (UTC)
Spread 0.030

ETH/USD

1,591.29 Price
-2.380% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 5.40

Still looking for a broker you can trust?

Join the 555.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading